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Recommendations for HIV Testing Services for
Inpatients and Outpatients in Acute-Care Hospital
Settings
Summary
These recommendations update previous recommendations regarding hu-
man immunodeficiency virus (HIV) counseling and testing of patients in
acute-care hospital settings ( 1). The revision was prompted by additional infor-
mation regarding both the rates at which patients admitted to some acute-care
hospitals have unrecognized HIV infection and the potential medical and public
health benefits of recognizing HIV infection in persons who have not developed
acquired immunodeficiency syndrome.
BACKGROUND
Since previous CDC recommendations regarding human immunodeficiency virus
(HIV) counseling and testing of patients in acute-care hospitals were published in
1987, studies have described HIV seroprevalence rates ranging from 0.3% to 6.0%
among various patient populations (2–7 ). In anonymous unlinked serologic surveys
conducted by CDC, 0.2%–8.9% of persons receiving care in emergency departments
and 0.1%–7.8% of persons admitted to acute-care hospitals were HIV antibody posi-
tive (8–10 ). In two studies in which data were obtained regarding previous HIV testing
or diagnosis, 63% and 65% of the HIV seropositive patients were unaware of their HIV
infection before hospital admission (2,5 ).
In the period 1989–1990, CDC conducted anonymous unlinked serologic surveys to
evaluate 13 hospital-specific variables as surrogate markers for hospital-specific HIV
seroprevalence (11 ). The diagnosis rate for acquired immunodeficiency syndrome
(AIDS) ([annual number of individual AIDS patients diagnosed and reported to the
health department/annual number of discharges] x 1,000) was the only hospital-spe-
cific characteristic associated with hospital-specific seroprevalence.
Based on the 1989–1990 surveys, an estimated 225,000 HIV-infected patients were
cared for in the 5,558 acute-care U.S. hospitals in 1990; 163,000 of these HIV-infected
patients were estimated to have a primary diagnosis other than HIV/AIDS. Of these
163,000 patients, 125,000 (77%) were admitted to the 593 (11%) hospitals with an AIDS
diagnosis rate of  ≥1.0 per 1,000 discharges; 110,000 (88%) of the 125,000 patients
were ages 15–54 years (Table 1). Thus, HIV testing of patients in this age range at these
hospitals would potentially identify 68% of infected persons hospitalized in the United
States for conditions other than HIV/AIDS.
Knowledge of their HIV infection status allows infected persons and their infected
partners to seek treatment with antiretroviral agents, prophylaxis against Pneumocys-
tis carinii pneumonia, tuberculosis skin testing and tuberculosis prophylaxis (if
appropriate), and other types of therapy and vaccines that may delay or prevent the
opportunistic infections associated with HIV infection (12–15 ). Such measures have
been shown to delay the onset of AIDS in infected persons and to prolong the lives of
persons with AIDS (16,17 ). In addition, counseling and testing may help some per-
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TABLE 1. Estimated efficiency of human immunodeficiency virus (HIV) testing in acute-care hospitals — United  States,
1990*
1990 AIDS
diagnosis
rate†
Number of
hospitals
Testing of patients of all ages Testing of patients ages 15–54 years
Number of
U.S.
hospital
patients
tested§
% of
acute-care
U.S.
hospital
patients¶
Number of
HIV+
patients
detected**
% of all
HIV+
acute-care
U.S.
hospital
patients††
Number of
U.S.
hospital
patients
tested§
% of
acute-care
U.S.
hospital
patients¶
Number of
HIV+
patients
detected**
% of all HIV+
acute-care U.S.
hospital
patients††
≥9.0    25    184,000  0.7  22,000 13.5     99,000  0.4  19,000†† 11.7
≥5.0    77    815,000  3.3  54,000 33.1    442,000  1.8  47,000†† 28.8
≥3.0   155  1,661,000  6.6  77,000 47.2    905,000  3.5  68,000†† 41.7
≥2.0   265  2,751,000 11.0  97,000 59.5  1,503,000  6.0  85,000†† 52.1
≥1.5   374  3,591,000 14.4 108,000 66.3  1,964,000  7.9  95,000†† 58.3
≥1.0   593  5,471,000 21.9 125,000 76.7  2,998,000 12.0 110,000†† 67.5
≥0.5 1,078  9,353,000 37.4 146,000 89.6  5,134,000 20.5 128,000†† 78.5
≥0.0 5,558 24,946,000 99.8 163,000 100 13,721,000 54.9 143,000§§ 87.7
 *Reprinted by permission of New England Journal of Medicine (327:449,1992).
† Acquired immunodeficiency syndrome (AIDS) diagnosis rate = ([annual number of individual AIDS patients diagnosed and reported
to the health department/annual number of discharges] x 1,000).
§ Excludes estimated number of patients with HIV/AIDS.
¶ Percentage of all patients, including patients with HIV/AIDS, in acute-care U.S. hospitals (N=25,000,000).
** Number of HIV+ patients who were admitted for conditions other than HIV/AIDS to hospitals with an AIDS diagnosis rate greater
than the given value.
†† Percentage of all HIV+ patients who were admitted to acute-care U.S. hospitals for conditions other than HIV/AIDS (N=163,000; 95%
confidence interval = 130,000 – 196,000).
§§ 95% Confidence interval = 116,000 – 169,000.
sons change high-risk sexual and drug-use behaviors and thereby prevent HIV trans-
mission to others (18–22 ).
HIV counseling and testing programs are not a substitute for universal precautions
or other infection-control techniques (23 ). Limited information does not support the
belief that knowledge of a patient’s HIV status decreases the risk of infection for
health-care workers through closer adherence to universal precautions (24,25 ). HIV
testing also must not be relied upon as a means of infection control in the hospital
because   a) test results may not be available in emergency settings, b) HIV tests will
not detect a newly infected person who has not yet seroconverted, and c) other blood-
borne pathogens (e.g., hepatitis B) may be present.
RECOMMENDATIONS
Voluntary and confidential HIV counseling and testing of patients in acute-care hos-
pitals are useful for a) assisting in differential diagnosis of medical conditions, b)
initiating early medical management of HIV infection, and c) informing infected per-
sons or persons at risk for infection about behaviors that can prevent HIV
transmission.
To promote the appropriate use of HIV counseling and testing services, CDC recom-
mends that acute-care facilities adopt the following guidelines*:
• Hospitals and associated clinics should encourage health-care providers to rou-
tinely ask patients about their risks for HIV infection and offer HIV counseling and
voluntary testing services to patients at risk (1 ). Patients should give informed
consent for testing in accordance with local laws.
• Hospitals and associated clinics should develop policies regarding provision of
routine HIV counseling and voluntary testing services. Other health-care institu-
tions such as drug treatment centers, mental health facilities, and private medical
practitioners are also encouraged to consider offering these services. The deci-
sion to offer these services routinely may be based on the HIV seroprevalence in
the patient population. This rate may be determined most directly by a repre-
sentative sample of unlinked anonymous specimens.† Alternatively, hospitals
*These guidelines are based in part on comments received by CDC at a meeting of consultants
in Atlanta, Georgia, April 5–6, 1990. The consultants represented the American College of
Emergency Physicians, American College of Obstetrics and Gynecology, American College of
Orthopedic Surgery, American Hospital Association, American Medical Association, American
Physicians for Human Rights, Association of State and Territorial Health Officers, Association
of State and Territorial Public Health Laboratory Directors, Council of State and Territorial
Epidemiologists, National Association of County Health Officers, National Association of Public
Hospitals, National Institutes of Health, National Medical Association, Occupational Safety and
Health Administration, and other technical experts. These Public Health Service recommenda-
tions may not reflect the views of all individual consultants or the organizations they
represented.
† To determine directly the rate of infection for a patient population, hospitals may consider
conducting anonymous unlinked serologic surveys (i.e., testing of serum or plasma samples
that were collected for other purposes and have had personal identifiers removed before
testing). For guidelines regarding the conduct of blinded HIV serosurveys in hospitals, contact:
Seroepidemiology Branch, Division of HIV/AIDS, Mailstop E-46, Centers for Disease Control
and Prevention (CDC), Atlanta, Georgia, 30333.
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and other health-care providers may elect to use an indirect marker of HIV sero-
prevalence, such as the AIDS diagnosis rate (defined above).
• Hospitals with an HIV seroprevalence rate of at least 1% or an AIDS diagnosis
rate ≥1.0 per 1,000 discharges should strongly consider adopting a policy of offer-
ing HIV counseling and testing routinely to patients ages 15–54 years.
• HIV counseling and testing procedures in the acute-care setting should be struc-
tured to facilitate confidential, voluntary patient participation and should include
a) pretest information on the testing policies of the institution or physician and b)
basic information about the medical implications of the test, the patient’s option
to receive more information, and the documentation of informed consent.
• HIV counseling and testing should be offered in nonemergency settings in which
patients are able to make an informed and voluntary decision regarding HIV test-
ing. HIV counseling and testing for purposes other than immediate medical care
should be deferred until a later time for persons who are too severely ill to under-
stand the pretest information or give informed consent.
• Test results should be provided to the patient in a confidential manner and for-
warded to state health departments in accordance with local law. Post-test
counseling for infected patients and those at increased risk should be performed
by trained health-care providers in accordance with existing CDC recommenda-
tions (1 ).
• Persons who decline HIV testing or who consent to testing and are HIV antibody
positive must not be denied needed medical care or provided suboptimal care.
HIV-infected persons should receive medical evaluation for HIV infection and
specific therapies and prevention services as needed. If therapeutic and preven-
tion services are not available, the acute-care facility or provider should establish
an effective referral system to ensure that these services will be provided.
• Facilities offering HIV testing and counseling should take necessary steps to pro-
tect the confidentiality of test results. The ability of facilities to assure
confidentiality of patients’ test information and the public’s confidence in that
ability are crucial to efforts to increase the number of persons being counseled
and tested for HIV infection. Moreover, to assure broad participation in counsel-
ing and testing programs, the public must be assured that persons found to be
HIV positive will not be subject to discrimination (1 ).
• HIV testing programs must not be used as a substitute for universal precautions
and other infection-control techniques.
THE ROLE OF HEALTH DEPARTMENTS
State and local health departments are a source for at least three forms of assis-
tance for implementing these recommendations. First, state and local health
departments can provide data to assist hospitals to determine their AIDS diagnosis
rate. Second, state and local health departments can provide technical assistance and
training for hospital staff responsible for HIV-related counseling and testing services in
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acute-care settings. Third, health departments can help hospitals by providing partner
notification services for HIV-infected patients, as well as additional prevention serv-
ices for uninfected patients who are at high risk for HIV infection. Effective and
ongoing collaboration between acute-care providers and health departments will im-
prove both prevention and treatment services for persons infected with HIV or at risk
for HIV infection.
References
1. CDC. Public health service guidelines for counseling and antibody testing to prevent HIV in-
fection and AIDS. MMWR 1987;36:509–15.
2. Gordin FM, Gibert C, Hawley HP, Willoughby A. Prevalence of human immunodeficiency virus
and hepatitis B virus in unselected hospital admissions: implications for mandatory testing
and universal precautions. J Infect Dis 1990;161:14–7.
3. Risi GF, Gaumer RH, Weeks S, Leete JK, Sanders CV. Human immunodeficiency virus: risk
of exposure among health care workers at a southern urban hospital. South Med J
1989;82:1079–82.
4. Lindsay MK, Peterson HB, Feng TI, Slade BA, Willis S, Klein L. Routine antepartum human
immunodeficiency virus infection screening in an inner city population. Obstet Gynecol
1989;74:289–94.
5. Kelen GD, DiGiovanna T, Bisson L, et al. Human immunodeficiency virus infection in emer-
gency department patients. JAMA 1989;262:516–22.
6. Soderstrom CA, Furth PA, Glasser D, Dunning RW, Groseclose SL, Cowley RA. HIV infection
rates in a trauma center treating predominantly rural blunt trauma victims. J Trauma
1989;29:1526–30.
7. Lewandowski C, Ognjan A, Rivers E, Pohlod D, Belian B, Saravolatz LD. HIV-1 and HTLV-I
seroprevalence in critically ill resuscitated emergency department patients (abstract Th.A.P.
9). V International Conference on AIDS, Montreal, Canada, 1989.
8. Marcus R, Bell D, Culver D, et al. Contact with blood of patients infected with HIV among
emergency care providers (ECPS) (abstract). VI International Conference on AIDS, San Fran-
cisco, CA, June 17–22,1990;1:276.
9. St. Louis ME, Olivo N, Critchley S, et al. Methods of surveillance for HIV infection at U.S.
sentinel hospitals. Public Health Rep 1990;105:140–6.
10. St. Louis ME, Rauch KJ, Petersen LR, et al. Seroprevalence rates of human immunodeficiency
virus infection at sentinel hospitals in the United States. N Engl J Med 1990;323:213–8.
11. Janssen RS, St. Louis ME, Satten GA, et al. HIV infection among patients in U.S. acute-care
hospitals: strategies for the counseling and testing of hospital patients. N Engl J Med
1992;327:445–52.
12. Hardy AM. AIDS knowledge and attitudes for January-March 1991:provisional data from the
National Health Interview Survey. Adv Data; No. 216, August 21, 1992. 
13. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunode-
ficiency virus infection. N Engl J Med 1990;322:941–9.
14. CDC. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected
with human immunodeficiency virus disease. MMWR 1989;38(suppl. S-5).
15. CDC. Screening for tuberculosis and tuberculous infection in high-risk populations and the
use of preventive therapy for tuberculous infection in the United States. Recommendations
of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990;39(No. RR-8).
16. CDC. Pneumococcal polysaccharide vaccine. MMWR 1989;38:64–8,73–6.
17. Rosenberg PS, Gail MH, Schrager LK, et al. National AIDS incidence trends and the extent
of zidovudine therapy in selected demographic and transmission groups. J Acquir Immune
Defic Syndr 1991;4:392–401.
18. CDC. Estimates of HIV prevalence and projected AIDS cases: summary of a workshop, October
31-November 1, 1989. MMWR 1990;39:110–2, 117–9.
19. DesJarlais DC, Friedman SR. The psychology of preventing AIDS among intravenous drug
users: a social learning conceptualization. Am Psychol 1988;43:865–70.
Vol. 42 / No. RR-2 MMWR 5
20. Godfried JP, Van Griensven MS, Ernest MM, et al. Impact of HIV antibody testing on changes
in sexual behavior among homosexual men in the Netherlands. Am J Public Health
1988;78:1575–7.
21. McCusker J, Stoddard AM, Mayer KH, Zapka JG, Morrisson C, Saltzman MS. Effect of HIV
antibody test knowledge on subsequent sex behaviors in a cohort of homosexually active
men. Am J Public Health 1988;78:462–7.
22. Higgins DL, Galavotti C, O’Reilly KR, Schnell DJ, Moore M, Rugg DL, Johnson R. Evidence
for the effects of HIV antibody counseling and testing on risk behaviors. JAMA 1991;266:2419–
29.
23. CDC. Recommendations for the prevention of HIV transmission in health-care settings. MMWR
1987;36(suppl. 2S).
24. Tokars J, Bell D, Culver D, Marcus R, Mendelson M, Sloan E, et al. Percutaneous injuries
during surgical procedures. JAMA 1992;267:2899–904.
25. Gerberding JL, Littell C, Tarkington A, Brown A, Schechter WP. Risk of exposure of surgical
personnel to patients’ blood during surgery at San Francisco General Hospital. N Engl J Med
1990;322:1788–93.
6 MMWR January 15, 1993
BLANK
Technical Guidance on HIV Counseling
The following experts served as consultants in the preparation
of this document:
Michael Baker
New York City Department of Health
New York, NY
Charles Bell, M.D.
Texas Department of Health
Austin, TX
Noel Brathwaite, Ph.D.
Association of Black Psychologists
Washington, DC
Wayne Brathwaite
Baltimore City Health 
 Department
Baltimore, MD
Barbara Cicatelli
Training Center for
Health Professionals
New York, NY
Peggy Clarke
American Social Health
 Association
Research Triangle Park, NC
Patricia Coury-Doniger, R.N.
University of Rochester
 Medical Center
Rochester, NY
Laura Fogt
AIDS Action Council
Washington, DC
William Freeman
National Association of People 
 With AIDS
Washington, DC
Helen Gasch, M.P.H.
Columbia University School of
 Public Health
New York, NY
Paul Mark Gibson, L.C.S.W.
City Clinic
San Francisco, CA
Bill Grace, Ph.D.
National Institute on
Drug Abuse
Rockville, MD
Heather Huszti, Ph.D.
Oklahoma Hemophilia Treatment
 Center
Oklahoma City, OK
Jane McCusker, M.D., Dr.P.H.
University of Massachusetts
 School of Public Health
Amherst, MA
Barbara McTague
New York State Department of Health
Albany, NY
Douglas Morgan, M.P.A.
New Jersey Department of Health
Trenton, NJ
Elena Perez, B.A., M.T.
New Jersey AIDS Education
 Training Center
Newark, NJ
Joanna Rinaldi
San Francisco General Hospital
San Francisco, CA
8 MMWR January 15, 1993
Technical Guidance on HIV Counseling — Continued
The following experts served as consultants in the preparation
of this document:
LeeAnn Roberts
Florida Department of Health and
 Rehabilitative Services
Tallahassee, FL
Dennis Sayers
Ohio Department of Health
Columbus, OH
Toni Shamplain
Shamplain and Associates, Inc.
Daytona Beach, FL
Vernon Shorty
DESIRE Narcotics
 Rehabilitation Center
New Orleans, LA
Hank Tavera, M.Ed.
City Clinic
San Francisco, CA
Carlos Vega, M.P.A.
Los Angeles AIDS Program Office
Los Angeles, CA
George Ware, M.S.
Colorado Department of Health
Denver, CO
Geoffrey Wertzberger, M.H.A.
Utah Department of Health
Salt Lake City, UT
Jackie White
Johns Hopkins Hospital
Baltimore, MD
Vol. 42 / No. RR-2 MMWR 9
BLANK
Technical Guidance on HIV Counseling
Summary
Human immunodeficiency virus counseling and testing services (HIV-CTS)
have been recommended by CDC since 1985, when serologic tests became
available to detect antibodies to HIV ( 1,2). In August 1987, CDC published the
Public Health Service Guidelines for Counseling and Antibody Testing to Prevent
HIV Infection and AIDS ( 3). These guidelines remain in effect today.
In December 1991, CDC convened a meeting of expert consultants to address
the need for additional technical guidance on the subject of HIV counseling. As a
result of that meeting, this document was developed to supplement the existing
guidelines and distributed to state and local health departments in February
1992. This document updates the original guidelines to address: relevance of
prevention messages; opportunities to provide and reinforce HIV-prevention
messages; messages tailored to behaviors, circumstances, and special needs of
clients; development of individualized, negotiated HIV risk-reduction plans; bar-
riers to return for post-test counseling; and appropriate, ongoing counselor
training.
INTRODUCTION
In 1991, more than 2 million serologic tests to detect antibodies for human immu-
nodeficiency virus (HIV) were performed at publicly funded HIV counseling and testing
sites (4 ). In addition to the provision of HIV counseling and testing services (HIV-CTS)
at publicly funded sites, many private providers, including physicians, offer HIV-CTS
(5 ).
CDC identifies the following as major functions of HIV-CTS: a) provide a convenient
opportunity for persons to learn their current HIV serostatus; b) allow such persons to
receive prevention counseling to help initiate behavior change to avoid infection, or, if
already infected, to prevent transmission to others; c) help persons obtain referrals to
receive additional prevention, medical-care, and other needed services; d) provide
prevention services and referrals for sex and needle-sharing partners of HIV-infected
persons (6 ).
To achieve the functions stated above and to address the specific HIV-prevention
needs of each client, HIV counseling must do more than provide factual information in
a didactic manner. This form of counseling — as the following recommendations de-
fine — should be “client-centered” and based on consultation with expert HIV
counselors, program managers, and other specialists.
RECOMMENDATIONS
HIV Prevention Messages
Counselors in programs that offer HIV-CTS should take advantage of all available
opportunities to provide clients with HIV-prevention messages.
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Clients manifest varying degrees of acceptance of HIV CTS. Some clients are highly
motivated to learn their HIV serostatus, while others may be wary or suspicious of
suggestions that they learn their HIV serostatus. Still others may not perceive them-
selves to be at risk for HIV infection and consider the test unnecessary. Changing
high-risk behavior is not an “all-or-nothing” process. Even after availing themselves
of HIV-CTS, seronegative clients may continue to engage in behaviors that place them
at risk for HIV infection.
Therefore, counselors should view all clinical encounters with clients as potential
opportunities to provide and reinforce HIV-prevention messages. These messages
should be clear and straight forward (e.g., “If you are not infected with HIV, you should
take steps to make sure you stay that way, and, if you are already infected, early treat-
ment can preserve your health by delaying the onset of illness.”)
Client-Centered Counseling
HIV counseling must be “client-centered.”
To fulfill its public health functions, HIV counseling must be client-centered; i.e.,
tailored to the behaviors, circumstances, and special needs of the person being
served. Risk-reduction messages must be personalized and realistic. Counseling
should be:
• Culturally competent (i.e., program services provided in a style and format sensi-
tive to cultural norms, values, and traditions that are endorsed by cultural leaders
and accepted by the target population);
• Sensitive to issues of sexual identity;
• Developmentally appropriate (i.e., information and services provided at a level of
comprehension that is consistent with the age and the learning skills of the per-
son being served);
• Linguistically specific (i.e., information is presented in dialect and terminology
consistent with the client’s language and style of communication).
HIV counseling is not a lecture. An important aspect of HIV counseling is the coun-
selor’s ability to listen  to the client in order to provide assistance and to determine
specific prevention needs.
Although HIV counseling should adhere to minimal standards in terms of providing
basic information, it should not become so routine that it is inflexible or unresponsive
to particular client needs. Counselors should avoid providing information that is irrele-
vant to their clients and should avoid structuring counseling sessions on the basis of
a data-collection instrument or form.
Client-Risk Assessment
HIV pretest counseling must include a personalized client-risk assessment.
A focused and tailored risk assessment is the foundation of HIV pretest counseling.
Risk assessment is a process whereby the counselor helps the client to assess and
take “ownership” of his/her risk for HIV infection. Client acceptance of risk is a critical
component of this assessment. Risk assessment is not a counselor’s passive appraisal
of the client’s behavior, such as checking off risks from a written list, but an interactive
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process between counselor and client. Risk assessment should be conducted in an
empathic manner with special attention given to the ongoing behaviors and circum-
stances (e.g., sexual history, sexually transmitted disease [STD] history, drug use) that
may continue to place the client at risk for HIV infection/transmission. For example,
clients who are being counseled in STD clinics, where they have come for the treat-
ment of a symptomatic STD (other than HIV), should be advised that their current
infection demonstrates that they are at increased risk for HIV.
Because the risk-assessment process serves as the basis for assisting the client in
formulating a plan to reduce risk, it is an essential component of all pretest counsel-
ing.
HIV Risk-Reduction Plan
HIV counseling should result in a personalized plan for the client to reduce the risk
of HIV infection/transmission.
HIV counseling is more than providing routine information. Such counseling
should also include the development of a personalized, negotiated HIV risk-reduction
plan. This plan should be based on the client’s skills, needs, and circumstances, and it
must be consistent with the client’s expressed or implied intentions to change behav-
iors. HIV counseling should not consist of the counselor “telling” the client what
he/she needs to do to prevent HIV infection/transmission, but instead should outline a
variety of specific options available to the client for reducing his/her own risk of HIV
infection/transmission. The counselor should confirm with the client that the
risk-reduction plan is realistic and feasible — otherwise, it is likely to fail.
When negotiating a personalized risk-reduction plan, counselors should be espe-
cially attentive to information provided by the client — especially information about
past attempts at preventive behaviors that were unsuccessful (e.g., intentions to use
condoms but failure to do so) and those which were successful. Identifying and dis-
cussing previous prevention failures help to ensure that the risk-reduction plan is
realistic, attentive to the clients’ prevention needs, and focused on actual barriers to
safer behaviors. Identifying previous prevention successes (e.g., successful negotia-
tion of condom use with a new sexual partner) offers the counselor the opportunity to
reinforce and support positive prevention choices.
An interactive risk assessment and a personalized risk-reduction plan developed
during pretest counseling ensure that clients receive adequate prevention informa-
tion, even before they learn the results of their tests. Counselors can use the client’s
expectation of test results to facilitate the development of a personalized
risk-reduction plan (e.g., “What do you expect your test results to be? Why? What will
you do if you are HIV seropositive? Is there anything different you will do if you are HIV
seronegative?”).
Post-test Counseling
Programs should take active steps to address the problem of failure to return for
post-test counseling.
Not all clients who receive pretest HIV counseling and testing return for post-test
counseling and test results. In 1991, 31 state and local health departments recorded
HIV counseling and testing data in such a way that analysis of individual post-test
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counseling return rates was possible. These project areas reported an average 63%
return rate for post-test counseling. However, this rate ranged from 41% to 86% and
varied by age, sex, race/ethnicity, self-reported risk behavior, service-delivery site, and
HIV serostatus. Analyses indicate that adolescents, blacks*, and clients served in fam-
ily-planning clinics and STD clinics, have lower return rates for HIV post-test
counseling (7 ).
HIV-CTS programs should be active in addressing the problem of failure to return
for HIV post-test counseling. Program managers should determine if specific opera-
tional barriers exist that prevent clients from returning for HIV post-test counseling
(e.g., excessive waiting time). Counselors should stress the importance of receiving
post-test counseling and should identify it as a specific component of the personalized
risk-reduction plan. HIV-CTS programs should give priority to contacting seropositive
and high-risk seronegative clients who have not returned to learn their test results and
have failed to receive post-test counseling.
As part of a comprehensive quality-assurance program, publicly funded counseling
and testing programs must monitor: a) blinded seroprevalence rates to assess the
extent of client access and acceptance of recommended counseling, testing, referral,
and partner-notification services (CTRPN); and b) the rates at which clients return to
receive HIV-antibody test results and post-test counseling.
When <50% of high-risk clients are receiving counseling and testing, or when low
return rates (e.g., <80% for seropositives and <60% for high-risk seronegatives) are
identified, documented “action steps” must be initiated to determine the reasons for
such low rates and to resolve barriers to clients in accessing services, learning their
test results, and obtaining counseling and referral services (6 ).
Counselors should routinely assess whether clients require additional post-test
counseling sessions.
Many HIV counselors have reported that some clients may require more than a
single post-test counseling session. Seropositive clients are often disturbed by the
realization that they have a life-threatening disease and often require additional coun-
seling and support. Seronegative clients who are at increased risk for HIV infection or
transmission may also require additional counseling to develop the skills needed to
practice safer behaviors.
Although CDC does not require its funded programs to routinely provide repeated
post-test counseling sessions, counselors and program managers should be aware
that certain clients may require additional support and further counseling opportuni-
ties. If deemed appropriate, additional counseling should be provided on-site or
through referral. In considering options for additional post-test counseling, program
managers should work with local community-based organizations that might offer
such services.
Programs should ensure that HIV CTS clients receive appropriate referrals.
Seronegative clients at continuing risk for HIV infection and HIV-infected clients
often require additional primary and secondary HIV-prevention services that may not
*CDC’s National Center for Prevention Services recognizes that a variety of terms are used and
preferred by different groups to describe race and ethnicity. Racial and ethnic terms used in
this document reflect the way data are collected and reported by official health agencies.
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be available on-site. For example, clients, whose drug use continues to place them at
risk for HIV infection should be referred for appropriate drug treatment. HIV-infected
clients should be provided (on-site or through referral) with immune system monitor-
ing and a medical evaluation to determine the need for anti-retroviral therapy and
prophylaxis for Pneumocystis  pneumonia. Facilitating referrals for these services, as
well as for tuberculosis (TB) and STD care as needed, are important aspects of HIV
post-test counseling.
Identifying appropriate referral sites (i.e., sites where appropriate services which
meet acceptable standards of quality are offered in a timely manner) should not be the
sole responsibility of the person performing HIV counseling. Program managers
should take the lead in identifying referral sites and developing programmatic rela-
tions (e.g., contracts and memoranda of understanding) with those sites to facilitate
needed client referrals.
Training and Counselor Feedback
Programs should provide training and counselor feedback to ensure the quality of
HIV-CTS.
Counselors, as well as their supervisors, require adequate training in HIV-CTS. In
addition to training on the scientific/public health aspects of HIV-CTS, training should
address other relevant issues such as substance abuse, human sexuality, the process
of behavior change, and the cultural perspectives of the clients being served.
Training for HIV counseling is not a one-time event — it should be an ongoing
process. An important component of ongoing quality assurance and training for HIV
counselors is routine, periodic observation during counseling sessions and sub-
sequent feedback. When a trained supervisor is not available to perform this
important function, routine observation should be done by trained peer counselors.
Performance standards that define expectations for the content and delivery quality of
counseling should be developed. (Note: observational supervision requires the con-
sent of the client being counseled.)
CONCLUSION
Publicly funded HIV-CTS are a major component of the national HIV-prevention pro-
gram (4 ). Further, national health promotion and disease prevention objectives for the
year 2000 target increases in the proportion of HIV-infected persons who have been
tested for HIV infection and the number of health-care facilities (e.g., family-planning
clinics, TB clinics, drug-treatment centers, primary-care clinics) where counseling and
testing is provided (8 ).
These recommendations, which supplement existing guidelines (3 ), focus on the
counseling portion of the HIV counseling and testing process — a cooperative en-
deavor that includes giving information and assisting the client in identifying his/her
HIV-prevention needs, and in developing a strategy to address those needs (9 ). These
guidelines stress the importance of ensuring that HIV counseling is empathic, a quality
known to be important in other clinical encounters (10 ).
By ensuring that counseling is empathic and “client-centered,” counselors will be
able to develop a realistic appraisal of the client’s level of risk and assess at which
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stage the client has reached in the behavior change process (11,12 ). Assessing the
client’s state of behavior change is important since intentions to reduce/modify risky
behavior or initiate/ increase healthy behavior will vary among clients. The “Stages of
Behavior Change” model recognizes that persons usually pass through a series of
steps before achieving consistently safe behavior—whether in terms of sexual or
drug-use behavior (13,14 ). These stages are: precontemplation (no intention to
change one’s behavior); contemplation (long-range intentions to change); ready for
action (short-term intentions to change); action (attempts to change); maintenance
(long-term consistent behavior change); and relapse (which can end the new behavior
or restart the process) (11,12,14 ).
Assessing the client’s stage of behavior change is necessary to ensure that preven-
tion messages are individually relevant —a crucial consideration if HIV counseling is
to effect behavior change. For instance, counseling messages that increase clients’
intentions to reduce risky behaviors are different from those required to maintain
safer behaviors and prevent relapse (15 ).
Cost-benefit analysis of HIV-CTRPN indicates that, even under conservative as-
sumptions, CDC’s expenditure on HIV-CTS results in a substantial net economic
benefit to society (16 ). Program managers and staff must have realistic expectations
about HIV counseling and testing programs. Although it is unlikely that a single epi-
sode of HIV counseling will result in the immediate and permanent adoption of safer
behaviors (17 ), client-centered HIV counseling and attendant prevention services (i.e.,
referral and partner notification) do contribute to the initiation and maintenance of
safer behaviors.
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